中文|CAS

logo
banner

Journals & Publications

Publications Papers

Papers

Non-small cell lung cancer: quantitative phenotypic analysis of CT images as a potential marker of prognosis
Jan 03, 2017Author：
PrintText Size A A

*Click Here to View Full Record
Title: Non-small cell lung cancer: quantitative phenotypic analysis of CT images as a potential marker of prognosis
Authors: Song, JD; Liu, ZY; Zhong, WZ; Huang, YQ; Ma, ZL; Dong, D; Liang, CH; Tian, J
Author Full Names: Song, Jiangdian; Liu, Zaiyi; Zhong, Wenzhao; Huang, Yanqi; Ma, Zelan; Dong, Di; Liang, Changhong; Tian, Jie
Source: Scientific Reports, 6 10.1038/srep38282 DEC 6 2016
Language: English
Abstract: This was a retrospective study to investigate the predictive and prognostic ability of quantitative computed tomography phenotypic features in patients with non-small cell lung cancer (NSCLC). 661 patients with pathological confirmed as NSCLC were enrolled between 2007 and 2014. 592 phenotypic descriptors was automatically extracted on the pre-therapy CT images. Firstly, support vector machine (SVM) was used to evaluate the predictive value of each feature for pathology and TNM clinical stage. Secondly, Cox proportional hazards model was used to evaluate the prognostic value of these imaging signatures selected by SVM which subjected to a primary cohort of 138 patients, and an external independent validation of 61 patients. The results indicated that predictive accuracy for histopathology, N staging, and overall clinical stage was 75.16%, 79.40% and 80.33%, respectively. Besides, Cox models indicated the signatures selected by SVM: "correlation of co-occurrence after wavelet transform" was significantly associated with overall survival in the two datasets (hazard ratio [HR]: 1.65, 95% confidence interval [CI]: 1.41-2.75, p = 0.010; and HR: 2.74, 95% CI: 1.10-6.85, p = 0.027, respectively). Our study indicates that the phenotypic features might provide some insight in metastatic potential or aggressiveness for NSCLC, which potentially offer clinical value in directing personalized therapeutic regimen selection for NSCLC.
ISSN: 2045-2322
Article Number: 38282
IDS Number: EE2NH
Unique ID: WOS:000689420800001